We provide advice and diagnostic support to referring teams for patients referred to us. We can provide comprehensive testing for causes of aHUS and C3G and appropriate follow-up. We will provide monitoring of patients commenced on eculizumab.
We also offer patient consultations:
- in our dedicated clinic in Newcastle, or also provide consultations remotely by video technology (Attend Anywhere) or by telephone.
- This clinic is also available to patients with aHUS or C3G, and families of those with aHUS who may also be at risk of the disease.
- Speak to your local physician if you would like to be referred – a referral.
We can also approve treatment with eculizumab and ravulizumab in patients with aHUS in accordance with NICE guidance (for aHUS) and clinical commission policy (for C3G).